Core needle biopsy revealed estrogen receptor-negative, progesterone receptor (PgR)-negative, and human epidermal growth factor receptor 2 (HER2)-positive invasive ductal carcinoma of the breast (Fig. 1). This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.